Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study

BACKGROUND: Platelet count (PLT) has been proved as an essential biomarker for the survival of hepatocellular carcinoma (HCC). However, the prognostic value of PLT change (ΔPLT) is still uncertain. The aim of this study was to explore the relationship between ΔPLT and HCC survival after transarteria...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Hepatocell Carcinoma
Autors principals: Lu, linbin, Zhang, Yan, Zheng, Peichan, Wu, Zhixian, Wang, Xuewen, Chen, Yaying, Chen, Xiong
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573485/
https://ncbi.nlm.nih.gov/pubmed/33117753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S274349
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars